November 26, 2020

News

FluoGuide’s presentation at Økonomisk Ugebrev’s Life Science event is now available

Copenhagen, Denmark, 26 November 2020 – Yesterday, FluoGuide A/S (“FluoGuide” or the “Company”) presented at Økonomisk Ugebrev’s Life Science event. The... [Read more]

November 20, 2020

Press release

FluoGuide A/S publishes interim report for the period January – September 2020

Copenhagen, Denmark, 20 November 2020 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January... [Read more]

November 9, 2020

Press release

First patient enrolled in the phase I/II clinical trial testing FG001 in patients with high grade glioma

Copenhagen, Denmark, 9 November 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to inform that the first patient today... [Read more]

October 26, 2020

Press release

FluoGuide awarded post doc grant to expand the pipeline

Copenhagen, Denmark, 26 October 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to announce that Innovation Fund Denmark has... [Read more]

October 14, 2020

Press release

FluoGuide A/S presents at BioStock Live

Copenhagen, Denmark, 14 October 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) presents at BioStock Live on Thursday 15 October 2020... [Read more]

September 21, 2020

Press release

FluoGuide appoints Henrik Moltke as Chief Financial Officer

Copenhagen, 21 September 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) today announces the appointment of Henrik Moltke as Chief Financial... [Read more]

September 3, 2020

Press release

FluoGuide announces regulatory approval from Danish Medicines Agency to commence Phase I/II clinical trial with FG001 in guiding surgery of high grade glioma (including glioblastoma)

Copenhagen, Denmark, 3 September 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to announce that the company has received... [Read more]

August 14, 2020

Press release

FluoGuide A/S interim report for the period January – June 2020

Copenhagen, Denmark, 14 August 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) today releases its results for the period 1 January–... [Read more]

August 13, 2020

Press release

FluoGuide A/S and LI-COR Biosciences sign agreement to develop uPAR targeted products to guide oncology surgery using LI-COR’s proprietary next-generation fluorophore IRDye 800CW

Copenhagen, Denmark, 13 August 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) has signed a non-exclusive supply and licensing agreement with... [Read more]